Inclusion | Refusal | Not proposed | |
---|---|---|---|
Number of patients | 17 | 13 | 25 |
Gender (n, %) | |||
Male | 10 (58.8%) | 5 (38.5%) | 15 (60.0%) |
Female | 6 (35.3%) | 5 (38.5%) | 10 (40.0%) |
Transsexual | 1 (5.9%) | 0 | 0 |
Missing data | 0 | 3 (23.1%) | 0 |
Age (year) (median, IQR) | 36 (31–42) | 52 (39–56) | 49 (41–54) |
Ethnicity | |||
White | 12 (70.6%) | 9 (69.2%) | 16 (64.0%) |
Black | 3 (17.6%) | 1 (7.7%) | 5 (20.0%) |
Other ethnicity | 2 (11.8%) | 0 | 4 (16.0%) |
Missing data | 0 | 3 (23.1%) | 0 |
Highest attained educational degree (n, %) | |||
Basica | 1 (5.9%) | 1 (7.7%) | 5 (20.0%) |
Medium/highb | 12 (70.6%) | 9 (69.2%) | 20 (80.0%) |
Unknown/Missing data | 4 (23.5%) | 3 (23.1%) | 0 |
Most likely source of HIV infection | |||
Sexual contact | 13 (76.4%) | 8 (61.5%) | 22 (88.0%) |
I.V. drug use/sexual contact (unclear which one) | 2 (11.8%) | 1 (7.7%) | 3 (12.0%) |
Other sources | 2 (11.8%) | 1 (7.7%) | 0 |
Missing data | 0 | 3 (23.1%) | 0 |
ART description at inclusionc | |||
NRTI + NNRTI | 7 (41.2%) | 9 (69.2%) | 15 (60.0%) |
NRTI + INSTI | 6 (35.3%) | 0 | 2 (8.0%) |
Other | 3 (17.6%) | 1 (7.7%) | 5 (20.0%) |
No treatment | 0 | 0 | 3 (12.0%) |
Missing data | 1 (5.9%) | 3 (23.1%) | 0 |
Switch of treatment during the study (n, %) | 7 (41.2%) | 4 (30.8%) | 6 (24.0%) |
Treatment stop | 0 | 1 (7.7%) | 1 (4.0%) |
Missing data | 0 | 3 (23.1%) | 0 |
ART line | |||
Naive patientsd | 9 (53.0%) | 0 | 0 |
Experienced patients | 8 (47.0%) | 10 (76.9%) | 24 (96.0%) |
Missing data | 0 | 3 (23.1%) | 1 (4.0%) |
VL at inclusion | |||
Patients with < 50 copies/mL (n, %) | 7 (41.2%) | 10 (76.9%) | 24 (96.0%) |
Patients with ≥50 copies/mL (n, %) | 10 (58.8%) | 0 | 1 (4.0%) |
Missing data (n, %) | 0 | 3 (23.1%) | 0 |
CD4 at inclusion (median, IQR) | |||
CD4 count (cell/mm3) | 583 (434–687) | 753 (659.5–931.5) | 648 (406.5–908.5) |
Reasons for proposal (n, %)e | – | ||
Difficult psychosocial context | 5 | 10 | |
Introduction of a new ART | 8 | 1 | |
Difficulties described by the patient | 2 | 1 | |
Suspected non-adherence by health professionals | 3 | 0 | |
Other | 1 | 1 | |
Reasons for patient refusal (n, %)e | – | – | |
Refused to change pharmacy | 11 | ||
Doesn’t feel the need for such support | 2 | ||
Fears about confidentiality | 2 |